Gemmer Asset Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Gemmer Asset Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-297	Closed	-$19K	–	1448
2014 Q3	$19K	Hold	297	–	–	0.01%	327
2014 Q2	$18K	Sell	297 -1,849	-86%	-$107K	0.01%	341
2014 Q1	$73K	Buy	+2,146	New	+$122K	0.05%	132

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

FIG

FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return

PFG

Pacific Financial Group Bellevue, Washington $209M AUM 22.2% 1-Year Est. Return

SCM

Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

Gemmer Asset Management's PJP Position: Q4 2014 in Review

Gemmer Asset Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2014, closing a stake of 297 shares — an estimated $19K sold.

Gemmer Asset Management first reported a position in PJP in Q1 2014 and held it in 3 quarters. The position peaked at $73K in Q1 2014. 97 funds tracked by Wall St. Rank hold PJP as of Q4 2014.

Gemmer Asset Management reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2014 after selling out during the quarter.
Gemmer Asset Management sold 297 Invesco Pharmaceuticals ETF shares in Q4 2014, an estimated $19K.
Gemmer Asset Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2014 and held it in 3 quarters.
Gemmer Asset Management's Invesco Pharmaceuticals ETF position peaked at $73K in Q1 2014.
97 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2014.

Based on Gemmer Asset Management's 13F filing for Q4 2014, filed 6 Feb 2015.